Header Logo

Ajaypal Singh

Concepts (540)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anemia
58
2023
91
15.870
Why?
Hematinics
47
2023
49
14.220
Why?
Renal Insufficiency, Chronic
37
2023
82
13.670
Why?
Erythropoietin
42
2023
49
10.990
Why?
Hemoglobins
43
2023
76
6.980
Why?
Kidney Diseases
26
2019
105
6.480
Why?
Renal Dialysis
38
2023
112
6.440
Why?
Kidney Failure, Chronic
30
2019
146
6.130
Why?
Tomography, X-Ray Computed
26
2019
675
4.350
Why?
Darbepoetin alfa
19
2023
19
3.200
Why?
Humans
157
2023
26260
2.820
Why?
Prolyl-Hydroxylase Inhibitors
4
2022
4
2.470
Why?
Epoetin Alfa
19
2022
21
2.230
Why?
Kidney
11
2019
168
2.210
Why?
Blast Injuries
5
2016
5
2.080
Why?
Barbiturates
5
2023
6
1.840
Why?
Middle Aged
64
2022
8541
1.840
Why?
Male
79
2022
14168
1.730
Why?
Glycine
3
2022
11
1.730
Why?
Female
79
2023
14520
1.700
Why?
Diabetes Mellitus, Type 2
10
2023
183
1.610
Why?
Randomized Controlled Trials as Topic
9
2013
303
1.580
Why?
Recombinant Proteins
22
2022
204
1.520
Why?
Cardiovascular Diseases
16
2022
338
1.520
Why?
Terrorism
5
2016
13
1.320
Why?
Aged
51
2022
8595
1.310
Why?
Iron
7
2023
21
1.270
Why?
Magnetic Resonance Imaging
8
2020
1069
1.230
Why?
Anemia, Iron-Deficiency
4
2015
5
1.210
Why?
Adult
40
2023
7516
1.190
Why?
Heart Failure
10
2019
148
1.150
Why?
Nephrology
4
2019
15
1.090
Why?
Mass Screening
3
2014
174
1.080
Why?
Foreign Bodies
3
2015
28
1.070
Why?
Chronic Disease
16
2010
413
1.030
Why?
Risk Factors
23
2020
2221
1.020
Why?
Clinical Trials as Topic
2
2022
211
1.000
Why?
Neoplasms
3
2023
224
0.980
Why?
Treatment Outcome
25
2023
3285
0.940
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2022
60
0.920
Why?
Lupus Nephritis
4
2006
31
0.920
Why?
Diabetic Nephropathies
5
2019
22
0.910
Why?
Biopsy, Needle
3
2012
105
0.910
Why?
Multiple Trauma
4
2016
4
0.870
Why?
Buprenorphine
1
2023
5
0.860
Why?
Benzhydryl Compounds
1
2023
4
0.860
Why?
Kidney Transplantation
4
2009
116
0.790
Why?
Liver Transplantation
3
2015
80
0.780
Why?
Opioid-Related Disorders
1
2023
59
0.780
Why?
Bone Diseases, Metabolic
3
2016
20
0.760
Why?
Prevalence
11
2018
441
0.760
Why?
Endoscopy
2
2015
154
0.760
Why?
Hypoxia-Inducible Factor-Proline Dioxygenases
4
2022
5
0.750
Why?
Vitamin D
3
2013
36
0.730
Why?
Farmers
1
2020
1
0.720
Why?
Colitis
3
2005
37
0.720
Why?
Prognosis
9
2017
710
0.720
Why?
Occupational Exposure
1
2020
16
0.710
Why?
United States Food and Drug Administration
3
2010
22
0.700
Why?
Metabolic Syndrome
2
2013
60
0.700
Why?
Stroke
9
2021
255
0.690
Why?
Practice Guidelines as Topic
7
2012
294
0.690
Why?
Erythropoiesis
4
2023
4
0.680
Why?
Myocardium
1
2020
95
0.680
Why?
Pandemics
1
2022
240
0.670
Why?
Retrospective Studies
17
2023
3283
0.660
Why?
Myocardial Infarction
5
2021
122
0.650
Why?
Hypertension
6
2018
230
0.650
Why?
Glomerular Filtration Rate
8
2016
51
0.640
Why?
Acute Kidney Injury
3
2014
44
0.610
Why?
Risk Assessment
12
2019
592
0.600
Why?
Fasciitis, Necrotizing
1
2018
5
0.590
Why?
Lower Extremity
1
2018
35
0.590
Why?
Ferric Compounds
4
2015
8
0.580
Why?
Marijuana Smoking
1
2017
3
0.560
Why?
Head Injuries, Penetrating
1
2017
1
0.550
Why?
Wounds, Gunshot
1
2017
3
0.550
Why?
Boston
6
2016
26
0.550
Why?
Cytokines
2
2008
224
0.550
Why?
Certification
2
2019
47
0.550
Why?
Contrast Media
6
2019
69
0.550
Why?
Ferritins
5
2017
9
0.540
Why?
Proteinuria
4
2013
57
0.540
Why?
Evidence-Based Medicine
4
2010
169
0.530
Why?
Pathology
1
2016
2
0.530
Why?
Societies, Medical
2
2019
144
0.520
Why?
Warfare
1
2016
12
0.510
Why?
Triage
1
2016
18
0.510
Why?
Cholangiocarcinoma
1
2015
4
0.510
Why?
Abdominal Injuries
1
2015
3
0.500
Why?
Bile Duct Neoplasms
1
2015
5
0.500
Why?
Renal Replacement Therapy
2
2015
23
0.500
Why?
Predictive Value of Tests
8
2020
422
0.500
Why?
Biliary Fistula
2
2006
5
0.500
Why?
Pelvis
1
2015
24
0.500
Why?
Neck Injuries
1
2015
3
0.490
Why?
Saudi Arabia
6
2016
8
0.490
Why?
Craniocerebral Trauma
1
2015
7
0.490
Why?
Education, Medical, Graduate
1
2016
72
0.490
Why?
Adolescent
12
2016
2172
0.490
Why?
Medicare
4
2010
113
0.480
Why?
United States
11
2017
2043
0.480
Why?
Gastrostomy
1
2015
7
0.480
Why?
Jejunostomy
1
2015
7
0.480
Why?
Consanguinity
2
2014
6
0.470
Why?
Diagnostic Imaging
1
2015
73
0.470
Why?
Radiography, Interventional
3
2012
18
0.470
Why?
Hypertension, Renal
1
2014
3
0.450
Why?
Death, Sudden, Cardiac
1
2014
10
0.450
Why?
Acute Disease
6
2017
190
0.450
Why?
Ventricular Fibrillation
1
2014
14
0.440
Why?
Cost of Illness
1
2014
41
0.440
Why?
India
4
2020
20
0.440
Why?
Vitamin D Deficiency
1
2013
10
0.430
Why?
Pediatrics
1
2013
44
0.420
Why?
Heart Arrest
1
2014
37
0.420
Why?
Biomedical Research
1
2013
58
0.420
Why?
Diagnosis, Differential
9
2019
343
0.410
Why?
Research Design
4
2008
190
0.410
Why?
Child
8
2016
1326
0.400
Why?
Disease Outbreaks
1
2012
79
0.400
Why?
Kidney Tubules
2
2009
8
0.400
Why?
Platelet Activation
1
2012
2
0.400
Why?
Splenic Diseases
1
2012
2
0.390
Why?
Blood Platelets
1
2012
39
0.390
Why?
Tissue Donors
3
2015
78
0.390
Why?
Spleen
1
2012
34
0.390
Why?
Intention to Treat Analysis
2
2021
8
0.390
Why?
Testis
2
2018
12
0.380
Why?
Abdomen, Acute
3
2008
5
0.380
Why?
Injections, Subcutaneous
3
2010
25
0.380
Why?
Fanconi Syndrome
1
2011
1
0.380
Why?
Red-Cell Aplasia, Pure
2
2008
2
0.380
Why?
Multiple Myeloma
1
2011
16
0.380
Why?
Surgery, Computer-Assisted
1
2012
47
0.380
Why?
Cross-Sectional Studies
6
2020
875
0.370
Why?
Appendicitis
2
2008
16
0.370
Why?
Liver
2
2015
154
0.370
Why?
Mass Casualty Incidents
3
2016
9
0.370
Why?
Bombs
3
2015
3
0.360
Why?
Prospective Studies
9
2022
1665
0.360
Why?
Preoperative Care
4
2015
120
0.350
Why?
Drug Approval
1
2010
7
0.350
Why?
Biliary Tract Diseases
1
2010
4
0.340
Why?
Reimbursement Mechanisms
1
2010
12
0.340
Why?
Aged, 80 and over
11
2017
4594
0.340
Why?
Vascular Diseases
1
2010
41
0.330
Why?
Magnetic Resonance Spectroscopy
2
2020
38
0.330
Why?
Liver Diseases
1
2010
33
0.330
Why?
Early Diagnosis
4
2014
58
0.320
Why?
Calcium Compounds
1
2009
2
0.320
Why?
Minerals
1
2009
6
0.320
Why?
Bone Density Conservation Agents
1
2009
14
0.310
Why?
Glomerulosclerosis, Focal Segmental
1
2009
35
0.310
Why?
Kidney Glomerulus
1
2009
48
0.310
Why?
Dose-Response Relationship, Drug
5
2013
330
0.310
Why?
Endothelium, Vascular
1
2008
28
0.310
Why?
Needles
1
2008
21
0.310
Why?
Cost Savings
1
2008
31
0.310
Why?
Pelvic Pain
1
2008
8
0.300
Why?
Hospital Mortality
2
2014
130
0.300
Why?
Muscle Neoplasms
1
2008
5
0.300
Why?
Abdominal Muscles
1
2008
6
0.300
Why?
Immunologic Factors
1
2008
33
0.300
Why?
Phosphates
1
2008
22
0.300
Why?
Data Interpretation, Statistical
1
2008
79
0.300
Why?
Acute Coronary Syndrome
1
2008
14
0.300
Why?
Abdominal Abscess
1
2008
3
0.300
Why?
Calculi
1
2008
2
0.300
Why?
Nephritis, Interstitial
2
2008
7
0.300
Why?
Appendectomy
1
2008
14
0.300
Why?
Bone and Bones
1
2009
116
0.300
Why?
Carcinoma, Renal Cell
1
2008
41
0.290
Why?
Multicenter Studies as Topic
2
2007
46
0.290
Why?
Cholangiopancreatography, Magnetic Resonance
2
2019
4
0.290
Why?
Drainage
3
2015
45
0.290
Why?
Diabetic Angiopathies
2
2019
6
0.280
Why?
Age Factors
4
2020
744
0.280
Why?
Drug-Related Side Effects and Adverse Reactions
1
2007
16
0.280
Why?
Pancreatic Fistula
1
2006
2
0.270
Why?
Ascites
1
2006
3
0.270
Why?
Diabetes Complications
1
2007
55
0.270
Why?
Biopsy
5
2019
202
0.270
Why?
Algorithms
4
2016
357
0.270
Why?
Tissue and Organ Procurement
1
2006
33
0.260
Why?
Severity of Illness Index
5
2012
853
0.260
Why?
Inflammation
1
2008
264
0.260
Why?
Penile Neoplasms
1
2005
2
0.250
Why?
Hernia, Abdominal
1
2005
2
0.250
Why?
Iron Compounds
1
2005
1
0.240
Why?
Metabolic Diseases
1
2005
10
0.240
Why?
Cohort Studies
7
2014
1801
0.230
Why?
Gallbladder Diseases
1
2004
3
0.230
Why?
Intestinal Fistula
1
2004
4
0.230
Why?
Colonic Diseases
1
2004
8
0.230
Why?
Pancreaticoduodenectomy
1
2004
12
0.230
Why?
Immunosuppressive Agents
2
2009
130
0.230
Why?
Fertility
1
2004
12
0.230
Why?
Infertility
1
2004
7
0.230
Why?
Mesenteric Vascular Occlusion
1
2004
4
0.230
Why?
Glomerulonephritis
1
2004
20
0.230
Why?
Cyclophosphamide
1
2004
41
0.230
Why?
Omentum
1
2004
7
0.230
Why?
Ovary
1
2004
20
0.230
Why?
Infarction
1
2004
29
0.220
Why?
Double-Blind Method
8
2022
411
0.220
Why?
Comorbidity
3
2013
468
0.220
Why?
Granuloma
1
2003
11
0.220
Why?
Incidence
3
2017
709
0.220
Why?
Ibuprofen
1
2003
12
0.220
Why?
Albuminuria
1
2023
14
0.220
Why?
Radiographic Image Enhancement
1
2004
27
0.220
Why?
Cholelithiasis
1
2003
5
0.220
Why?
Nurse's Role
1
2005
121
0.220
Why?
Gastric Outlet Obstruction
1
2003
2
0.220
Why?
Patient Education as Topic
3
2010
141
0.220
Why?
Opiate Substitution Treatment
1
2023
5
0.220
Why?
Narcotic Antagonists
1
2023
10
0.220
Why?
Glucosides
1
2023
2
0.220
Why?
Survival Analysis
3
2009
242
0.210
Why?
Hyperparathyroidism, Secondary
2
2016
3
0.210
Why?
Patients
1
2023
31
0.210
Why?
Catheter Ablation
2
2015
61
0.210
Why?
Gastroenterology
1
2022
10
0.200
Why?
Inflammatory Bowel Diseases
1
2004
87
0.200
Why?
Young Adult
5
2018
1948
0.200
Why?
Survival Rate
3
2014
315
0.190
Why?
Colonic Polyps
1
2022
34
0.190
Why?
Models, Biological
1
2003
292
0.190
Why?
Data Collection
1
2022
88
0.190
Why?
Logistic Models
2
2020
353
0.190
Why?
Injections, Intravenous
4
2008
29
0.180
Why?
Disease Progression
4
2017
676
0.180
Why?
Tobacco, Smokeless
1
2020
1
0.180
Why?
Confidence Intervals
3
2012
90
0.180
Why?
Child, Preschool
4
2016
652
0.180
Why?
Quality of Life
5
2023
606
0.180
Why?
Analgesics, Opioid
1
2023
211
0.180
Why?
Time Factors
5
2018
1347
0.180
Why?
International Cooperation
2
2019
18
0.170
Why?
Alcohol Drinking
1
2020
75
0.170
Why?
Hospitalization
4
2017
290
0.170
Why?
Pathologists
1
2019
1
0.170
Why?
Pathology, Clinical
1
2019
1
0.170
Why?
Mitochondrial Proteins
1
2019
42
0.160
Why?
C-Reactive Protein
2
2017
92
0.160
Why?
Catheterization
2
2012
44
0.160
Why?
Intracellular Signaling Peptides and Proteins
1
2019
51
0.160
Why?
Lupus Erythematosus, Systemic
1
2002
173
0.160
Why?
Administration, Oral
1
2019
105
0.160
Why?
Choledocholithiasis
1
2019
2
0.160
Why?
Deglutition Disorders
1
2019
34
0.160
Why?
Running
2
2016
14
0.160
Why?
Metformin
1
2019
19
0.160
Why?
Hydroxamic Acids
1
2018
5
0.160
Why?
Ultrasonography, Interventional
2
2012
66
0.160
Why?
Histone Deacetylase Inhibitors
1
2018
8
0.160
Why?
Metabolomics
1
2018
17
0.160
Why?
Health Knowledge, Attitudes, Practice
2
2010
170
0.150
Why?
Anterior Wall Myocardial Infarction
1
2018
1
0.150
Why?
Myositis
1
2019
34
0.150
Why?
Leiomyoma
2
2008
7
0.150
Why?
Autoimmune Diseases
1
2019
48
0.150
Why?
Fractures, Closed
1
2018
1
0.150
Why?
Foot Injuries
1
2018
1
0.150
Why?
ST Elevation Myocardial Infarction
1
2018
10
0.150
Why?
Ankle Injuries
1
2018
8
0.150
Why?
Radiation Injuries
1
2018
27
0.150
Why?
Health Literacy
1
2020
104
0.150
Why?
Drug Costs
2
2008
12
0.150
Why?
Up-Regulation
2
2010
166
0.150
Why?
Ultrasonography
2
2018
224
0.150
Why?
Biosimilar Pharmaceuticals
1
2017
2
0.150
Why?
Practice Patterns, Physicians'
2
2010
112
0.150
Why?
Patient Selection
2
2010
184
0.150
Why?
Sex Distribution
2
2018
77
0.140
Why?
Coronary Artery Disease
1
2018
98
0.140
Why?
Nephrologists
1
2017
4
0.140
Why?
Follow-Up Studies
6
2014
1722
0.140
Why?
Sensitivity and Specificity
5
2018
473
0.140
Why?
Antihypertensive Agents
1
2017
75
0.140
Why?
Glasgow Coma Scale
1
2017
8
0.140
Why?
Cognition Disorders
2
2014
970
0.140
Why?
Executive Function
2
2014
111
0.130
Why?
Blood Pressure
1
2017
197
0.130
Why?
Public Health
1
2017
68
0.130
Why?
Emergency Service, Hospital
1
2019
236
0.130
Why?
Pilot Projects
3
2017
397
0.130
Why?
Radiography
1
2018
594
0.130
Why?
Explosions
1
2016
1
0.130
Why?
Drug Monitoring
2
2006
15
0.130
Why?
Program Development
1
2016
62
0.130
Why?
Muscle, Skeletal
1
2019
386
0.130
Why?
Photochemotherapy
1
2015
3
0.130
Why?
Cholangiopancreatography, Endoscopic Retrograde
1
2015
7
0.130
Why?
Endosonography
1
2015
7
0.130
Why?
Diphosphates
1
2015
1
0.120
Why?
Dialysis Solutions
1
2015
5
0.120
Why?
Risk Reduction Behavior
3
2011
45
0.120
Why?
Trauma Centers
1
2015
8
0.120
Why?
Radiopharmaceuticals
2
2007
49
0.120
Why?
Endoscopy, Digestive System
1
2015
8
0.120
Why?
Intensive Care Units, Pediatric
1
2014
14
0.120
Why?
Wounds, Penetrating
1
2014
7
0.120
Why?
Curriculum
1
2016
160
0.120
Why?
Corneal Opacity
1
2014
2
0.120
Why?
Acidosis, Renal Tubular
1
2014
2
0.120
Why?
Sex Factors
2
2013
456
0.120
Why?
Enteral Nutrition
1
2015
59
0.110
Why?
Electric Countershock
1
2014
10
0.110
Why?
Kidney Function Tests
2
2017
20
0.110
Why?
Defibrillators, Implantable
1
2014
11
0.110
Why?
Diabetes Mellitus
2
2018
127
0.110
Why?
Pedigree
1
2013
67
0.110
Why?
Animals
3
2018
3551
0.110
Why?
Coronary Angiography
1
2014
71
0.110
Why?
Kaplan-Meier Estimate
3
2012
160
0.110
Why?
Cardiopulmonary Resuscitation
1
2014
20
0.110
Why?
Chi-Square Distribution
2
2010
131
0.110
Why?
Electrocardiography
1
2014
95
0.110
Why?
Critical Care
1
2016
195
0.110
Why?
Blood Viscosity
1
2013
10
0.110
Why?
Age Distribution
1
2013
84
0.110
Why?
Middle East
1
2012
5
0.100
Why?
Calcinosis
2
2014
36
0.100
Why?
Regression Analysis
2
2012
249
0.100
Why?
P-Selectin
1
2012
2
0.100
Why?
CD40 Ligand
1
2012
8
0.100
Why?
Cell-Derived Microparticles
1
2012
8
0.100
Why?
Splenic Artery
1
2012
1
0.100
Why?
Sclerosing Solutions
1
2012
2
0.100
Why?
Aneurysm, False
1
2012
4
0.100
Why?
Sclerotherapy
1
2012
4
0.100
Why?
Magnetic Resonance Imaging, Interventional
1
2012
9
0.100
Why?
Pneumothorax
1
2012
11
0.100
Why?
Population Surveillance
1
2012
103
0.100
Why?
Thrombosis
2
2017
48
0.100
Why?
Spermatozoa
2
2018
7
0.100
Why?
Postoperative Hemorrhage
1
2012
24
0.100
Why?
Drug Therapy, Combination
3
2008
169
0.090
Why?
Microscopy, Electron
1
2011
56
0.090
Why?
Bone Marrow Transplantation
1
2011
21
0.090
Why?
Risk
2
2010
197
0.090
Why?
Embolization, Therapeutic
1
2012
56
0.090
Why?
Multivariate Analysis
4
2015
296
0.090
Why?
Calcium
2
2016
344
0.090
Why?
Ethanol
1
2012
120
0.090
Why?
Hepatectomy
1
2011
61
0.090
Why?
Iron, Dietary
1
2010
1
0.090
Why?
Ferrosoferric Oxide
1
2010
1
0.090
Why?
Hepcidins
1
2010
1
0.090
Why?
Indicators and Reagents
1
2010
12
0.090
Why?
Antimicrobial Cationic Peptides
1
2010
3
0.090
Why?
Cardiac Output
1
2010
14
0.090
Why?
Immunohistochemistry
1
2011
349
0.090
Why?
Awareness
1
2010
44
0.090
Why?
Glomerulonephritis, Membranous
1
2010
6
0.090
Why?
Case-Control Studies
2
2011
567
0.090
Why?
Drug Labeling
1
2010
2
0.090
Why?
Consumer Product Safety
1
2010
6
0.090
Why?
Feasibility Studies
1
2010
199
0.080
Why?
Health Care Reform
1
2010
14
0.080
Why?
Erythrocytes
1
2009
20
0.080
Why?
Developing Countries
1
2009
14
0.080
Why?
Global Health
1
2009
37
0.080
Why?
Truth Disclosure
1
2009
5
0.080
Why?
Antineoplastic Agents
1
2011
178
0.080
Why?
Length of Stay
2
2014
290
0.080
Why?
Hematocrit
1
2009
14
0.080
Why?
Parent-Child Relations
1
2009
38
0.080
Why?
Sirolimus
1
2009
19
0.080
Why?
Massachusetts
1
2009
19
0.080
Why?
Ergocalciferols
1
2009
1
0.080
Why?
Calcitriol
1
2009
4
0.080
Why?
Phosphorus
1
2009
7
0.080
Why?
HIV Seropositivity
1
2009
51
0.080
Why?
Cilazapril
1
2008
1
0.080
Why?
Reference Values
2
2013
189
0.080
Why?
Glomerulonephritis, IGA
1
2008
8
0.080
Why?
Ovarian Diseases
1
2008
1
0.080
Why?
Publication Bias
1
2008
5
0.080
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2008
24
0.080
Why?
Gadolinium
1
2008
9
0.080
Why?
Medicaid
1
2008
31
0.080
Why?
Puerperal Disorders
1
2008
3
0.080
Why?
Radiography, Abdominal
1
2008
4
0.080
Why?
Prednisone
1
2008
54
0.080
Why?
Kidney Diseases, Cystic
1
2008
2
0.080
Why?
Leuprolide
1
2008
2
0.080
Why?
Menorrhagia
1
2008
3
0.080
Why?
Probability
1
2008
86
0.080
Why?
Renal Insufficiency
1
2008
13
0.080
Why?
Interleukin-8
1
2008
18
0.080
Why?
Antineoplastic Agents, Hormonal
1
2008
15
0.080
Why?
Polycythemia
1
2008
1
0.080
Why?
Odds Ratio
1
2009
247
0.080
Why?
Fournier Gangrene
1
2008
1
0.070
Why?
Sclerosis
1
2008
61
0.070
Why?
Nephrectomy
1
2008
30
0.070
Why?
Caregivers
1
2009
119
0.070
Why?
Disorders of Excessive Somnolence
1
2008
12
0.070
Why?
Interleukin-6
1
2008
73
0.070
Why?
Hypoglycemia
1
2008
12
0.070
Why?
Graft Rejection
1
2008
62
0.070
Why?
Iatrogenic Disease
1
2008
25
0.070
Why?
Clinical Competence
1
2010
227
0.070
Why?
Arteriovenous Shunt, Surgical
1
2008
18
0.070
Why?
Periodicals as Topic
1
2008
37
0.070
Why?
Angioplasty, Balloon, Coronary
1
2008
37
0.070
Why?
Metabolic Clearance Rate
1
2007
5
0.070
Why?
Half-Life
1
2007
11
0.070
Why?
Biological Availability
1
2007
16
0.070
Why?
Primary Prevention
1
2008
35
0.070
Why?
Cardiac Catheterization
1
2008
60
0.070
Why?
Pregnancy Complications
1
2008
46
0.070
Why?
Adrenal Cortex Hormones
1
2008
101
0.070
Why?
Diffusion of Innovation
1
2007
29
0.070
Why?
Hematopoiesis
1
2007
13
0.070
Why?
Organotechnetium Compounds
1
2007
7
0.070
Why?
Ciprofloxacin
1
2007
12
0.070
Why?
Anti-Bacterial Agents
1
2010
362
0.070
Why?
Tumor Necrosis Factor-alpha
1
2008
180
0.070
Why?
Pregnancy
1
2008
312
0.070
Why?
Patient Dropouts
1
2007
27
0.070
Why?
Transplantation, Homologous
1
2008
260
0.070
Why?
Tuberculosis
1
2007
20
0.070
Why?
Bone Diseases
1
2007
24
0.070
Why?
Cause of Death
2
2019
55
0.070
Why?
Proportional Hazards Models
3
2013
321
0.070
Why?
Morbidity
1
2006
49
0.070
Why?
Fluoroscopy
1
2006
40
0.070
Why?
Bias
1
2006
39
0.070
Why?
Surveys and Questionnaires
2
2009
1034
0.070
Why?
Laparoscopy
1
2008
144
0.070
Why?
Mortality
2
2019
81
0.070
Why?
Graft Survival
1
2006
96
0.070
Why?
Inpatients
1
2008
142
0.070
Why?
Catheters, Indwelling
1
2006
24
0.060
Why?
Postoperative Complications
1
2012
825
0.060
Why?
Biomarkers
1
2008
556
0.060
Why?
Cadaver
1
2006
363
0.060
Why?
Causality
1
2005
52
0.060
Why?
Infusions, Intravenous
1
2005
50
0.060
Why?
Histology
1
2004
3
0.060
Why?
Evaluation Studies as Topic
1
2005
33
0.060
Why?
Patient Care Planning
1
2005
45
0.060
Why?
Penis
1
2005
81
0.060
Why?
Melena
1
2004
1
0.060
Why?
Ovum
1
2004
3
0.060
Why?
Oocytes
1
2004
6
0.060
Why?
Embryo, Mammalian
1
2004
21
0.060
Why?
Mesenteric Artery, Superior
1
2004
3
0.060
Why?
Cryopreservation
1
2004
16
0.060
Why?
Cell Transplantation
1
2004
22
0.060
Why?
Nephritis
1
2003
1
0.060
Why?
Nephrosis
1
2003
4
0.060
Why?
Iothalamic Acid
1
2003
2
0.060
Why?
Technetium Tc 99m Pentetate
1
2003
2
0.060
Why?
Iodine Radioisotopes
1
2003
14
0.050
Why?
Crohn Disease
1
2004
41
0.050
Why?
Syndrome
1
2003
73
0.050
Why?
Colitis, Ulcerative
1
2004
62
0.050
Why?
Endoscopy, Gastrointestinal
1
2022
10
0.050
Why?
Nucleosomes
1
2002
3
0.050
Why?
Biopsy, Fine-Needle
1
2022
60
0.050
Why?
Memory
2
2014
292
0.050
Why?
Postoperative Period
1
2003
326
0.050
Why?
Colonoscopy
1
2022
72
0.050
Why?
Autoantibodies
1
2002
78
0.050
Why?
Apoptosis
1
2002
190
0.050
Why?
Rural Population
1
2020
25
0.040
Why?
Myoglobinuria
1
2019
1
0.040
Why?
Carotid Artery, Internal
1
2019
7
0.040
Why?
Magnetic Resonance Angiography
1
2019
29
0.040
Why?
Rhabdomyolysis
1
2019
6
0.040
Why?
Education, Distance
1
2019
15
0.040
Why?
Muscle Weakness
1
2019
33
0.040
Why?
Creatinine
2
2009
51
0.040
Why?
Sperm Motility
1
2018
2
0.040
Why?
Myocardial Revascularization
1
2018
16
0.040
Why?
Mental Health
1
2020
113
0.040
Why?
Organ Size
1
2018
95
0.040
Why?
Cardiovascular Agents
1
2018
24
0.040
Why?
Longitudinal Studies
2
2014
1295
0.040
Why?
Age of Onset
1
2018
94
0.040
Why?
Cerebral Infarction
1
2019
148
0.040
Why?
Veins
1
2017
7
0.040
Why?
Systole
1
2017
16
0.040
Why?
Thrombolytic Therapy
1
2018
47
0.040
Why?
Therapeutic Equivalency
1
2017
2
0.040
Why?
Arteries
1
2017
14
0.040
Why?
Anastomosis, Surgical
1
2017
25
0.040
Why?
Hypertrophy, Left Ventricular
1
2017
24
0.040
Why?
Hypotension
1
2017
28
0.040
Why?
Transferrin
2
2008
6
0.040
Why?
Body Weight
1
2017
137
0.040
Why?
Smoking
1
2018
164
0.030
Why?
Mice, Inbred C57BL
1
2018
420
0.030
Why?
Patient Acuity
1
2016
7
0.030
Why?
Parathyroid Hormone
1
2016
20
0.030
Why?
Image Enhancement
1
2015
45
0.030
Why?
Administration, Intravenous
1
2015
21
0.030
Why?
Cholesterol, HDL
1
2015
27
0.030
Why?
Cholesterol, LDL
1
2015
29
0.030
Why?
Single-Blind Method
1
2015
108
0.030
Why?
Dietary Supplements
1
2015
65
0.030
Why?
Triglycerides
1
2015
56
0.030
Why?
Oliguria
1
2014
1
0.030
Why?
Diuretics
1
2014
6
0.030
Why?
Burns, Chemical
1
2014
2
0.030
Why?
Hypoxia
1
2014
34
0.030
Why?
Sodium-Bicarbonate Symporters
1
2014
1
0.030
Why?
Imaging, Three-Dimensional
1
2015
193
0.030
Why?
Basal Ganglia Diseases
1
2014
6
0.030
Why?
Homozygote
1
2014
21
0.030
Why?
Sequence Deletion
1
2014
15
0.030
Why?
Mice
1
2018
1380
0.030
Why?
Respiration, Artificial
1
2014
111
0.030
Why?
Recurrence
1
2014
288
0.030
Why?
Sepsis
1
2014
136
0.030
Why?
Principal Component Analysis
1
2013
25
0.030
Why?
Infant
1
2014
541
0.030
Why?
Mental Status Schedule
1
2013
88
0.030
Why?
Hemoglobinometry
1
2012
1
0.020
Why?
Linear Models
1
2013
238
0.020
Why?
Drug Delivery Systems
1
2012
31
0.020
Why?
Analysis of Variance
1
2012
259
0.020
Why?
Thailand
1
2009
10
0.020
Why?
Interviews as Topic
1
2009
132
0.020
Why?
Neuropsychological Tests
1
2013
1192
0.020
Why?
Disease Management
1
2009
104
0.020
Why?
Drug Interactions
1
2008
36
0.020
Why?
Health Expenditures
1
2007
17
0.020
Why?
Radionuclide Imaging
1
2007
41
0.020
Why?
Osteomyelitis
1
2007
18
0.020
Why?
False Positive Reactions
1
2007
34
0.020
Why?
Equipment Failure
1
2006
36
0.020
Why?
Costs and Cost Analysis
1
2006
28
0.020
Why?
Demography
1
2006
67
0.020
Why?
Ambulatory Care
1
2006
66
0.020
Why?
Singh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (540)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_